NMRA vs SLB · $283.5M cap vs P/E 12, rev $35.71B
Neumora Therapeutics, Inc. (NMRA) versus Schlumberger NV (SLB) — a side-by-side from cached financials, not a winner call.
Neumora Therapeutics, Inc. (NMRA) is a biotechnology company listed on NASDAQ.
Schlumberger NV (SLB) is a oil & gas equipment & services company listed on US.
NMRA does not have a complete income-statement cache yet.
Latest reported SLB revenue for 2025-12-31 was $35.71B. Net income was $3.37B. Revenue was down 1.6% from 2024-12-31 to 2025-12-31. SLB currently screens at market cap $48.16B and trailing P/E 12.1.
NMRA currently screens at market cap $283.5M. SLB currently screens at market cap $48.16B and trailing P/E 12.1.
Not investment advice. Open the NMRA and SLB stock pages for the full models.
Not investment advice.